id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0242-0015,FDA,FDA-2013-N-0242,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Approval,2019-12-31T05:00:00Z,2019,12,2019-12-31T05:00:00Z,,2019-12-31T14:54:02Z,2019-28249,0,0,090000648425db8d
FDA-2013-N-0242-0014,FDA,FDA-2013-N-0242,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Current Good
Manufacturing Practices for Positron Emission Tomography Drugs",Notice,30 Day Proposed Information Collection,2019-09-04T04:00:00Z,2019,9,2019-09-04T04:00:00Z,2019-10-05T03:59:59Z,2019-09-04T13:38:46Z,2019-19030,0,0,0900006483ee78af
FDA-2013-N-0242-0010,FDA,FDA-2013-N-0242,Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practices for Positron Emission Tomography Drugs,Notice,60 Day Proposed Information Collection,2019-03-14T04:00:00Z,2019,3,2019-03-14T04:00:00Z,2019-05-14T03:59:59Z,2019-07-30T11:13:58Z,2019-04716,0,0,0900006483adea28